Published in Drug Week, June 9th, 2006
The technology utilizes halloysite nanotubes, which are being commercialized by NaturalNano, Inc., (NNAN, N3N). These nanotubes, which are hollow inorganic nanostructures derived from clay, allow the linear, controlled release of drugs. "In addition, the nanochopping technology being developed allows for achieving precisely defined sizes of nanotubes to ensure the predictable performance and dosing required for a given drug," stated Stephen Curry, president...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.